GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Itama Ranoraya Tbk (ISX:IRRA) » Definitions » Capex-to-Operating-Income

PT Itama Ranoraya Tbk (ISX:IRRA) Capex-to-Operating-Income : 0.06 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is PT Itama Ranoraya Tbk Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

PT Itama Ranoraya Tbk's Capital Expenditure for the three months ended in Mar. 2024 was Rp-506.51 Mil. Its Operating Income for the three months ended in Mar. 2024 was Rp8,459.14 Mil.

Hence, PT Itama Ranoraya Tbk's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.06.


PT Itama Ranoraya Tbk Capex-to-Operating-Income Historical Data

The historical data trend for PT Itama Ranoraya Tbk's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Itama Ranoraya Tbk Capex-to-Operating-Income Chart

PT Itama Ranoraya Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial 0.11 0.16 0.13 0.06 1.30

PT Itama Ranoraya Tbk Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.42 - - 0.06

Competitive Comparison of PT Itama Ranoraya Tbk's Capex-to-Operating-Income

For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Itama Ranoraya Tbk's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where PT Itama Ranoraya Tbk's Capex-to-Operating-Income falls into.



PT Itama Ranoraya Tbk Capex-to-Operating-Income Calculation

PT Itama Ranoraya Tbk's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-34803.373) / 26794.536
=1.30

PT Itama Ranoraya Tbk's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-506.512) / 8459.144
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Itama Ranoraya Tbk  (ISX:IRRA) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


PT Itama Ranoraya Tbk Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of PT Itama Ranoraya Tbk's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Itama Ranoraya Tbk (ISX:IRRA) Business Description

Traded in Other Exchanges
N/A
Address
MT. Haryono Square Lantai 1 Unit 101, Jl. Otto Iskandardinata Raya No. 390, No. 390 Jakarta Timur, Jakarta, IDN, 13330
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. The key revenue generating segments of the company are Sterile Non-Electromedical Medical Equipment and In Vitro Diagnostic product.

PT Itama Ranoraya Tbk (ISX:IRRA) Headlines

No Headlines